Changing our microbiome: probiotics in dermatology

Y Yu, S Dunaway, J Champer, J Kim… - British Journal of …, 2020 - academic.oup.com
Background Commensal bacteria are a major factor in human health and disease
pathogenesis. Interest has recently expanded beyond the gastrointestinal microbiome to …

[HTML][HTML] The human microbiota and skin cancer

YR Woo, SH Cho, JD Lee, HS Kim - International Journal of Molecular …, 2022 - mdpi.com
Skin cancer is the most common type of cancer in the US with an increasing prevalence
worldwide. While ultraviolet (UV) radiation is a well-known risk factor, there is emerging …

Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes

L Wang, X Ni, KR Covington, BY Yang, J Shiu… - Nature …, 2015 - nature.com
Sézary syndrome is a rare leukemic form of cutaneous T cell lymphoma characterized by
generalized redness, scaling, itching and increased numbers of circulating atypical T …

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and …

E Olsen, E Vonderheid, N Pimpinelli… - Blood, The Journal …, 2007 - ashpublications.org
The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group
classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions …

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

M Duvic, R Talpur, X Ni, C Zhang, P Hazarika, C Kelly… - Blood, 2007 - ashpublications.org
The activity and safety of the histone deacetylase inhibitor vorinostat (suberoylanilide
hydroxamic acid, SAHA) were evaluated in patients with refractory cutaneous T-cell …

Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results

M Duvic, K Hymes, P Heald, D Breneman… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: Cutaneous T-cell lymphomas (CTCL) are malignancies of T cells appearing as
skin lesions and are responsive to retinoid therapy. Safety and efficacy of a novel RXR …

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

LM Lindahl, A Willerslev-Olsen… - Blood, The Journal …, 2019 - ashpublications.org
It has been proposed that CD4 T-cell responses to Staphylococcus aureus (SA) can
inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T-cell …

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides

LY McGirt, P Jia, DA Baerenwald… - Blood, The Journal …, 2015 - ashpublications.org
The pathogenesis of mycosis fungoides (MF), the most common cutaneous T-cell lymphoma
(CTCL), is unknown. Although genetic alterations have been identified, none are considered …

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma

M Duvic, AG Martin, Y Kim, E Olsen… - Archives of …, 2001 - jamanetwork.com
Objectives To determine the safety and efficacy of oral bexarotene (Targretin capsules;
Ligand Pharmaceuticals Incorporated, San Diego, Calif). Design The effects of 2 …

Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome

S Ladhani, CL Joannou, DP Lochrie… - Clinical microbiology …, 1999 - Am Soc Microbiol
The exfoliative (epidermolytic) toxins of Staphylococcus aureus are the causative agents of
the staphylococcal scalded-skin syndrome (SSSS), a blistering skin disorder that …